Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors

por Buzatto, I.P.C., Ribeiro-Silva, A., Andrade, J.M., Carrara, H.H.A., Silveira, W.A., Tiezzi, D.G.
Publicado 2017

Immunohistochemical expression of Drosha is reduced in eutopic and ectopic endometrium of women with adenomyosis

por Ormenezi, I., Ribeiro-Silva, A., Rosa-e-Silva, J.C., Meola, J., Candido-dos-Reis, F.J., Poli-Neto, O.B.
Publicado 2022